Table 1

Sociodemographic characteristics and comorbidities of the overall cohort undergoing SAVR and TAVI between 2000 and 2023

SAVR (n=1 39 990)TAVI (n=39 655)P value
Age (years)
 Mean (SD)70.6 (10.8)80.8 (7.7)<0.001
 Median (min, max)72.4 (18.0, 101.3)82.0 (20.8, 101.9)
Sex
 Male89 250 (63.8 %)22 550 (56.9 %)<0.001
 Female50 735 (36.2 %)17 105 (43.1 %)
 Unknown<10 (0.0 %)<10 (0.0 %)
Ethnicity
 White134 430 (96.0 %)37 945 (95.7 %)<0.001
 Asian or Asian British3145 (2.2 %)1075 (2.7 %)
 Black or black British910 (0.6 %)365 (0.9 %)
 Mixed or multiple ethnic groups450 (0.3 %)140 (0.4 %)
 Unknown1055 (0.8 %)130 (0.3 %)
IMD quintiles
 1 (most deprived)20 845 (14.9 %)5145 (13.0 %)<0.001
 224 950 (17.8 %)6775 (17.1 %)
 329 980 (21.4 %)8430 (21.3 %)
 431 245 (22.3 %)9105 (23.0 %)
 5 (least deprived)29 970 (21.4 %)9725 (24.5 %)
 Unknown3000 (2.1 %)480 (1.2 %)
Comorbidities
 Coronary artery disease55 470 (39.6 %)15 530 (39.2 %)0.101
 Diabetes30 900 (22.1 %)12 455 (31.4 %)<0.001
 Hypertension97 650 (69.8 %)33 640 (84.8 %)<0.001
 Asthma/Chronic obstructive airways disease28 130 (20.1 %)12 595 (31.8 %)<0.001
 Cerebrovascular disease11 405 (8.1 %)5070 (12.8 %)<0.001
 Chronic kidney disease23 785 (17.0 %)15 670 (39.5 %)<0.001
 Heart failure34 245 (24.5 %)17 375 (43.8 %)<0.001
 Peripheral arterial disease10 725 (7.7 %)5750 (14.5 %)<0.001
  • The Statistical Disclosure rules dictate that for counts <10 we had to round them to 10, which is why these are presented as ‘<10’ in the table.

  • IMD, Indices of Multiple Deprivation; SAVR, surgical aortic valve replacement ; TAVI, transcatheter aortic valve implantation.